Rosenblum Silverman Sutton S F Inc Heron Therapeutics, Inc. Transaction History

Rosenblum Silverman Sutton S F Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$13.67 - $17.77 $891,106 - $1.16 Million	-65,187 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $9,365 - $18,464	-860 Reduced 1.3%	65,187 $959,000
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $137,767 - $330,749	-13,467 Reduced 16.94%	66,047 $775,000
Q4 2019 Jan 24, 2020	SELL	$17.42 - $26.61 $1.06 Million - $1.61 Million	-60,564 Reduced 43.24%	79,514 $1.87 Million
Q3 2019 Nov 01, 2019	SELL	$16.36 - $21.39 $7,754 - $10,138	-474 Reduced 0.34%	140,078 $2.59 Million

Q2 2019 Jul 31, 2019	SELL	$16.93 - $26.22 $26,834 - $41,558	-1,585 Reduced 1.12%	140,552 $2.61 Million
Q1 2019 Apr 25, 2019	BUY	$23.15 - $28.34 $3.29 Million - $4.03 Million	142,137 New	142,137 $3.47 Million

168

119M

151K

103K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $325M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.